|
SF3A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.4706000000263E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.173250E-04 |
| Normal-vs-Stage2 |
1.338160E-03 |
| Normal-vs-Stage3 |
4.01720000042793E-07 |
| Normal-vs-Stage4 |
7.85240000023002E-07 |
| Stage1-vs-Stage2 |
7.560000E-01 |
| Stage1-vs-Stage3 |
1.043370E-01 |
| Stage1-vs-Stage4 |
7.749700E-02 |
| Stage2-vs-Stage3 |
4.191800E-01 |
| Stage2-vs-Stage4 |
3.656800E-01 |
| Stage3-vs-Stage4 |
8.120000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.30169999998675E-06 |
| Normal-vs-AfricanAmerican |
4.779600E-02 |
| Normal-vs-Asian |
2.336700E-03 |
| Caucasian-vs-AfricanAmerican |
3.503800E-01 |
| Caucasian-vs-Asian |
6.985200E-01 |
| AfricanAmerican-vs-Asian |
6.037200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.76144999999295E-05 |
| Normal-vs-Female |
1.5650499999964E-05 |
| Male-vs-Female |
5.776000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.63190000000469E-05 |
| Normal-vs-Age(41-60Yrs) |
3.5088000000072E-05 |
| Normal-vs-Age(61-80Yrs) |
1.09310000051543E-07 |
| Normal-vs-Age(81-100Yrs) |
1.426170E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.554000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.038360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.600600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.193200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.481400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.885000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.097800E-03 |
| Classical-VS-Follicular |
5.56859999999437E-05 |
| Classical-VS-Other |
2.771400E-01 |
| Classical-VS-Normal |
5.596300E-04 |
| Tall-VS-Follicular |
4.633000E-01 |
| Tall-VS-Other |
9.676000E-01 |
| Tall-VS-Normal |
1.55254999999466E-05 |
| Follicular-VS-Other |
8.010200E-01 |
| Follicular-VS-Normal |
4.5874000043078E-08 |
| Other-VS-Normal |
1.849560E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.76848999999812E-05 |
| Normal-vs-N1 |
1.331600000265E-07 |
| N0-vs-N1 |
1.039780E-01 |
|
|
